GL1X · GenesisL1 explorer

MolNFT v1 · #55619 · protein

Structure of BVDV1 envelope glycoprotein E2, PH8

2YQ2 · BVDV1 E2: “Structure of BVDV1 envelope glycoprotein E2, PH8”. X-ray diffraction, 1 ligand (NAG), 1 pocket (best druggability 0.32). MolNFT v1 #55619 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2YQ2
Type
protein
Length
662 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
BVDV1 E2
Ligands
NAG
Pockets
1 · best druggability 0.32

Structure

x-ray diffraction · 2 distinct chains · 3% helix, 47% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABVDV1 E2protein3323% helix, 48% strand—
BBVDV1 E2protein3303% helix, 46% strand—

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1760.320.7313empty

Interfaces

1 interface between chains.

  • A–B · 2377 Ų buried · 30 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 17 disulfide, 6 glycan (disulfide, N-glycosylation).

Compared structures

  • 2YQ2 · Structure of BVDV1 envelope glycoprotein E2, pH8 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.